We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive Cancers

News   Jan 24, 2018 | Original story from Southern Methodist University

 
Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive Cancers

Multi-drug resistant cancer cells absorb red die, indicating they've died after treatment with the chemotherapeutic daunorubicin and a P-gp inhibitor. (Credit: SMU)

 
 
 

RELATED ARTICLES

Computer-Aided Material Design Program Summarizes Thousands of Articles in One Chart

News

NIMS and the Toyota Technological Institute at Chicago have jointly developed a Computer-Aided Material Design (CAMaD) system that enables information from thousands of scientific and technical articles to be summarized in a single chart, rationalizing and expediting material design.

READ MORE

The Key to Unlocking HPC's Value?

News

Large-scale supercomputing is essential to solving complex questions about our world. But storage platforms essential for these advanced computer systems have been stuck in a rigid framework that required users to either choose between customization of features or high availability. Now, researchers have found a way to give high-performance computing data systems the flexibility to thrive with a framework called BespoKV, perhaps helping to one day achieve the HPC goal of performing at the exascale, or 1 billion billion calculations per second.

READ MORE

Shortage of Gene Silencing Molecules Linked to Pediatric Brain Tumor Development

News

Researchers have added to evidence that a shortage of specific tiny molecules that silence certain genes is linked to the development and growth of pediatric brain tumors known as low-grade gliomas.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE